Breaking News Instant updates and real-time market news.

OVID

Ovid Therapeutics

$3.31

-0.07 (-2.07%)

16:23
12/10/18
12/10
16:23
12/10/18
16:23

Armistice Capital reports 6.5% passive stake in Ovid Therapeutics

OVID Ovid Therapeutics
$3.31

-0.07 (-2.07%)

08/06/18
PIPR
08/06/18
NO CHANGE
Target $20
PIPR
Overweight
Ovid Therapeutics shares should recover from here, says Piper Jaffray
Piper Jaffray analyst Tyler Van Buren attributes Ovid Therapeutics' selloff to the lack of statistical significance on the domain-based endpoints in the Phase 2 STARS trial, but he believes the shares will recover from these levels as appreciation for the just-reported data grows and as the report of OV935 proof of concept dEE data near year-end approaches. The analyst, who thinks the dEE data has "exciting potential," keeps an Overweight rating and $20 price target on Ovid shares, which are down 35% to $6.20 in afternoon trading.
08/10/18
PIPR
08/10/18
NO CHANGE
Target $20
PIPR
Overweight
Piper sees value coming back into Ovid shares after pullback
Shares of Ovid Therapeutics have pulled back following the recent Angelman's data release, but investors underappreciate the exploratory nature of what was the first study of its kind, Piper Jaffray analyst Tyler Van Buren tells investors in a research note. Further, he believes the FDA will give flexibility in designing a registrational program for OV101 given the lack of treatments option and the significant unmet needs that exists for these patients. The analyst maintains an Overweight rating on Ovid with a $20 price target, believing share value will accrue as investors get a greater appreciation for the OV101 program and opportunity.
11/14/18
CANT
11/14/18
INITIATION
Target $10
CANT
Overweight
Ovid Therapeutics initiated with an Overweight at Cantor Fitzgerald
Price target $10.
11/15/18
CANT
11/15/18
INITIATION
Target $10
CANT
Overweight
Ovid Therapeutics initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald analyst Charles Duncan last night initiated coverage of Ovid Therapeutics with an Overweight rating and $10 price target. The analyst rolled out coverage on five Neuro-Innovator companies, focusing on "innovative technologies that can lead to breakthrough and disruptive treatments." He believes all five companies have "growth potential that exceeds current valuations, over time."

TODAY'S FREE FLY STORIES

AXAS

Abraxas Petroleum

$0.28

(0.00%)

10:11
11/19/19
11/19
10:11
11/19/19
10:11
Downgrade
Abraxas Petroleum rating change  »

Abraxas Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:10
11/19/19
11/19
10:10
11/19/19
10:10
General news
Quarterly Services Report [Advance] Iformation Revenue data reported »

Quarterly Services Report…

10:10
11/19/19
11/19
10:10
11/19/19
10:10
General news
Quarterly Services Report [Advance] Iformation Revenue data reported »

Quarterly Services Report…

BRY

Berry Petroleum

$10.90

-0.405 (-3.58%)

10:10
11/19/19
11/19
10:10
11/19/19
10:10
Downgrade
Berry Petroleum rating change  »

Berry Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:10
11/19/19
11/19
10:10
11/19/19
10:10
General news
E-Commerce Retail Sales E- Q/Q Change SAAR data reported »

E-Commerce Retail Sales…

CHK

Chesapeake

$0.59

-0.0496 (-7.70%)

10:10
11/19/19
11/19
10:10
11/19/19
10:10
Downgrade
Chesapeake rating change  »

Chesapeake downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPE

Callon Petroleum

$3.83

-0.115 (-2.92%)

10:10
11/19/19
11/19
10:10
11/19/19
10:10
Downgrade
Callon Petroleum rating change  »

Callon Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EOG

EOG Resources

$70.11

-1.15 (-1.61%)

10:10
11/19/19
11/19
10:10
11/19/19
10:10
Upgrade
EOG Resources rating change  »

EOG Resources upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FXI

iShares China Large-Cap ETF

$41.74

0.455 (1.10%)

10:10
11/19/19
11/19
10:10
11/19/19
10:10
Options
$1.5M Call buyer in China ETF »

$1.5M Call buyer in China…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FANG

Diamondback Energy

$74.48

-1.24 (-1.64%)

10:09
11/19/19
11/19
10:09
11/19/19
10:09
Downgrade
Diamondback Energy rating change  »

Diamondback Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGY

Magnolia Oil & Gas

$11.32

-0.15 (-1.31%)

10:09
11/19/19
11/19
10:09
11/19/19
10:09
Downgrade
Magnolia Oil & Gas rating change  »

Magnolia Oil & Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OAS

Oasis Petroleum

$2.49

-0.135 (-5.14%)

10:09
11/19/19
11/19
10:09
11/19/19
10:09
Downgrade
Oasis Petroleum rating change  »

Oasis Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWN

Southwestern Energy

$1.96

-0.015 (-0.76%)

10:08
11/19/19
11/19
10:08
11/19/19
10:08
Downgrade
Southwestern Energy rating change  »

Southwestern Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVGO

Broadcom

$322.68

11.73 (3.77%)

, T

AT&T

$38.65

-0.96 (-2.42%)

10:08
11/19/19
11/19
10:08
11/19/19
10:08
On The Fly
AT&T, MSG Networks downgrades among today's top analyst calls »

Check out today's top…

AVGO

Broadcom

$322.68

11.73 (3.77%)

T

AT&T

$38.65

-0.96 (-2.42%)

I

Intelsat

$5.90

-2.08 (-26.07%)

MSGN

MSG Networks

$17.82

-0.675 (-3.65%)

IMAX

Imax

$21.28

0.4 (1.92%)

AMC

AMC Entertainment

$8.79

0.3 (3.53%)

CNK

Cinemark

$34.42

0.295 (0.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 02

    Dec

  • 06

    Dec

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

  • 12

    Dec

  • 16

    Dec

  • 17

    Dec

  • 29

    Jan

WHLR

Wheeler REIT

$1.85

(0.00%)

10:08
11/19/19
11/19
10:08
11/19/19
10:08
Hot Stocks
Stilwell Group urges Wheeler REIT shareholders to vote for director nominees »

The Stilwell Group, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

CHWY

Chewy

$22.50

0.395 (1.79%)

10:05
11/19/19
11/19
10:05
11/19/19
10:05
Options
Chewy call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

TGT

Target

$110.21

-0.38 (-0.34%)

, AMZN

Amazon.com

$1,756.23

3.53 (0.20%)

10:04
11/19/19
11/19
10:04
11/19/19
10:04
Earnings
Fly Intel: What to watch in Target's earnings report »

Target (TGT) is scheduled…

TGT

Target

$110.21

-0.38 (-0.34%)

AMZN

Amazon.com

$1,756.23

3.53 (0.20%)

WMT

Walmart

$120.20

-0.01 (-0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 20

    Nov

FBIO

Fortress Biotech

$1.85

-0.04 (-2.12%)

10:04
11/19/19
11/19
10:04
11/19/19
10:04
Conference/Events
Fortress Biotech management to meet with Philadelphia Securities Association »

Group Luncheon Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

MMS

Maximus

$75.60

-1.93 (-2.49%)

10:01
11/19/19
11/19
10:01
11/19/19
10:01
Earnings
Maximus says fiscal 2020 revenue will be stronger in first half »

Maximus said in earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

PFG

Principal Financial

$54.77

0.5 (0.92%)

10:01
11/19/19
11/19
10:01
11/19/19
10:01
Conference/Events
Principal Financial management to meet with Sandler ONeill »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

  • 11

    Dec

VAL

Valaris

$3.82

-0.38 (-9.05%)

10:00
11/19/19
11/19
10:00
11/19/19
10:00
Hot Stocks
Valaris falls -8.8% »

Valaris is down -8.8%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KSS

Kohl's

$49.52

-8.875 (-15.20%)

10:00
11/19/19
11/19
10:00
11/19/19
10:00
Hot Stocks
Kohl's falls -15.2% »

Kohl's is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 05

    Dec

I

Intelsat

$6.14

-1.84 (-23.06%)

10:00
11/19/19
11/19
10:00
11/19/19
10:00
Hot Stocks
Intelsat falls -23.4% »

Intelsat is down -23.4%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

AMRX

Amneal Pharmaceuticals

$3.05

0.215 (7.58%)

10:00
11/19/19
11/19
10:00
11/19/19
10:00
Hot Stocks
Amneal Pharmaceuticals rises 8.8% »

Amneal Pharmaceuticals is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JKS

JinkoSolar

$16.95

2.07 (13.91%)

10:00
11/19/19
11/19
10:00
11/19/19
10:00
Hot Stocks
JinkoSolar rises 13.9% »

JinkoSolar is up 13.9%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 10

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.